Resmed Inc. buy Royal Bank of Canada
Start price
15.07.25
/
50%
€220.80
Target price
15.07.26
€251.96
Performance (%)
-3.13%
Price
25.02.26
€213.90
Summary
This prediction is currently active. With a performance of -3.13%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 15.07.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -2.640% | -2.640% |
| iShares Core DAX® | 0,05 % | 1,31 % |
| iShares Nasdaq 100 | 1,60 % | -0,90 % |
| iShares Nikkei 225® | 3,06 % | 12,95 % |
| iShares S&P 500 | 0,82 % | 0,70 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $294.00 price target on the stock.
Ratings data for RMD provided by MarketBeat